Skip to main content

Table 2 In vitro PK parameters

From: An integrated pharmacokinetics ontology and corpus for text mining

Experiment types

Parameters

Description

Unit

References

Single Drug Metabolism Experiment

Km

Michaelis-Menten constant.

mg L-1

Segel p28.

 

Vmax

Maximum velocity of the enzyme activity.

mg h-1 mg-1 protein

Segel p19

 

CLint

Intrinsic metabolic clearance is defined as ratio of maximum metabolism rate, Vmax, and the Michaelis-Menten constant, Km.

ml h-1 mg-1 protein

RT p165

 

Metabolic ratio

Parent drug/metabolite concentration ratio

NA

 
 

fmenzyme

Fraction of drug systemically available that is converted to a metabolite through a specific enzyme.

NA

RT xiii

Single Drug Transporter Experiment

Papp

The apparent permeability of compounds across the monolayer cells.

cm/sec

Transport Consortium

 

Re

Re is the ratio of basolateral to apical over apical to basolateral.

NA

Transport Consortium

 

Radioactivity

Total radioactivity in plasma and bile samples is measured in a liquid scintillation counter

dpm/mg protein

Transport Consortium

 

Uptake Volume

The amount of radioactivity associated with the cells divided by its concentration in the incubation medium.

ul/mg protein

Transport Consortium

Drug Interaction Experiment

IC50

Inhibitor concentration that inhibits to 50% of enzyme activity.

mg L-1

 
 

Ki

Inhibition rate constant for competitive inhibition, noncompetitive inhibition, and uncompetitive inhibition.

mg L-1

Segel p103

 

Kdeg

The natural degradation rate constant for the Enzyme.

h-1

Rostami-Hodjegan and Tucker

 

KI

The concentration of inhibitor associated with half maximal Inactivation in the mechanism based inhibition.

mg L-1

Rostami-Hodjegan and Tucker

 

Kinact

The maximum degradation rate constant in the presence of a high concentration of inhibitor in the mechanism based inhibition.

h-1

Rostami-Hodjegan and Tucker

 

Emax

Maximum induction rate

Unit free

Rostami-Hodjegan and Tucker

 

EC50

The concentration of inducer that is associated with the half maximal induction.

mg L-1

Rostami-Hodjegan and Tucker

Type of Drug Interactions

Competitive inhibition, noncompetitive inhibition, uncompetitive inhibition, mechanism based inhibition, and induction.

Rostami-Hodjegan and Tucker

  
  1. Note: Segel H. Irwin. Enzyme Kinetics - Behavior and analysis of rapid equilibrium and steady state enzyme systems. John Wiley & Sons, Inc. 1975, New York. Rostami-Hodjegan Amin and Tucker Geoff ‘In silico’ simulations to assess the ‘in vivo’ consequences of ‘in vitro’ metabolic drug-drug interactions. Drug Discovery Today, 2004, 1, 441-448. The International Transporter Consortium, Membrane transporters in drug development. Nature Review Drug Discovery, 9, 215-236. Rowland Malcolm and Tozer N. Thomas Clinical Pharmacokinetics Concepts and Applications, 3rd edition. 1995, Lippincott Williams & Wilkins.